What is Nektar Therapeutics's debt-to-assets?

Nektar Therapeutics (NKTR) reported debt-to-assets of 0.1× in Q1 2026.

How has Nektar Therapeutics's debt-to-assets changed year-over-year?

Nektar Therapeutics's debt-to-assets decreased by 72.2% year-over-year, from 0.4× to 0.1×.

What is the long-term trend for Nektar Therapeutics's debt-to-assets?

Over 5 years (2020 to 2025), Nektar Therapeutics's debt-to-assets has grown at a 25.6% compound annual growth rate (CAGR), from 0.1× to 0.3×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Nektar Therapeutics NKTR Debt-to-assets

Debt-to-assets at other companies

AmgenAMGN

0.6×0.0×

Regeneron PharmaceuticalsREGN

0.1×0.0×

ImmunityBio, Inc.IBRX

0.7×-0.4×

Apogee Therapeutics, Inc.APGE

0×0.0×

ImmunomeIMNM

0×0.0×

Vera TherapeuticsVERA

0.1×0.0×

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Calculated from Nektar Therapeutics’s reported figures.

total debt/total assets=0.1×

Based on the most recent quarter.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's debt-to-assets?: Nektar Therapeutics (NKTR) reported debt-to-assets of 0.1× in Q1 2026.
How has Nektar Therapeutics's debt-to-assets changed year-over-year?: Nektar Therapeutics's debt-to-assets decreased by 72.2% year-over-year, from 0.4× to 0.1×.
What is the long-term trend for Nektar Therapeutics's debt-to-assets?: Over 5 years (2020 to 2025), Nektar Therapeutics's debt-to-assets has grown at a 25.6% compound annual growth rate (CAGR), from 0.1× to 0.3×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.